Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)

ClinicalTrials.gov ID: NCT01455701

Public ClinicalTrials.gov record NCT01455701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)

Study identification

NCT ID
NCT01455701
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
11 participants

Conditions and interventions

Interventions

  • Tocilizumab Drug

Drug

Eligibility (public fields only)

Age range
Up to 24 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2012
Primary completion
Jul 27, 2016
Completion
Jul 12, 2017
Last update posted
Nov 3, 2019

2012 – 2017

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Children's National Medical Center; Pediatric Rheumatology Washington D.C. District of Columbia 20010-2970
The University of Chicago;Department of Pediatrics Chicago Illinois 60649
University of Louisville Research Foundation, Inc; Kosair Charities Pediatric Clinical Research Unit Louisville Kentucky 40202
The Floating Hospital for Children at Tufts Medical Center Boston Massachusetts 02111
Children's Hospital Boston Pediatric Medicine Boston Massachusetts 02115
Children's Speciality Center of Nevada Las Vegas Nevada 89109
Hackensack University Medical Center; Pediatric Rheumatology Hackensack New Jersey 07601
Cincinnati Children'S Hospital Medical Center; Division of Rheumatology Cincinnati Ohio 45229-3039
Children's Hospital Of Pittsburgh Pittsburgh Pennsylvania 15224

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01455701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01455701 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →